Schedule 13G ownership disclosure

Rhythm Pharmaceuticals Inc

Security class unavailable · CUSIP: 76243J105

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,216,911
Percent of class
11.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-24-005549
Form type
SC 13G/A
Filer
PRIMECAP MANAGEMENT CO/CA/
CIK
CIK 763212
Filed
Nov 12, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub